Sebastien Hazard
- Oncology top 10%
- Pulmonary and Respiratory Medicine
- Reproductive Medicine top 10%
- Molecular Biology
- Genetics
- Co-authors
- Larry LeonSuresh S. RamalingamPriscilla K. BrastianosMohammad JahanzebE. Dawn FlickMichael P. KostyMansoor Raza MirzaJulie R. Brahmer
- Topics
- PARP inhibition in cancer therapy (14 papers)Ovarian cancer diagnosis and treatment (10 papers)Lung Cancer Treatments and Mutations (9 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer Research
- Partner nations
- United StatesSpainDenmark
In The Last Decade
Sebastien Hazard
29 papers receiving 305 citations
Peers
Comparison fields: 5 of 41
- Oncology 254
- Pulmonary and Respiratory Medicine 142
- Reproductive Medicine 93
- Molecular Biology 58
- Genetics 39
Countries citing papers authored by Sebastien Hazard
This map shows the geographic impact of Sebastien Hazard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastien Hazard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastien Hazard more than expected).
Fields of papers citing papers by Sebastien Hazard
This network shows the impact of papers produced by Sebastien Hazard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastien Hazard. The network helps show where Sebastien Hazard may publish in the future.
Co-authorship network of co-authors of Sebastien Hazard
This figure shows the co-authorship network connecting the top 25 collaborators of Sebastien Hazard. A scholar is included among the top collaborators of Sebastien Hazard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastien Hazard. Sebastien Hazard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 16 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 32 | |
| 6 | 2 | |
| 7 | 16 | |
| 8 | 31 | |
| 9 | 3 | |
| 10 | 2 | |
| 11 | 10 | |
| 12 | 8 | |
| 13 | 7 | |
| 14 | 12 | |
| 15 | 1 | |
| 16 | 21 | |
| 17 | 5 | |
| 18 | 35 | |
| 19 | 8 | |
| 20 | 44 |
About Sebastien Hazard
Sebastien Hazard is a scholar working on Reproductive Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 312 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (14 papers), Ovarian cancer diagnosis and treatment (10 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Reproductive Medicine (93 citations), Oncology (254 citations) and Pulmonary and Respiratory Medicine (142 citations). Sebastien Hazard has collaborated with scholars based in United States, Spain and Denmark. Frequent co-authors include Larry Leon, Suresh S. Ramalingam, Priscilla K. Brastianos, Mohammad Jahanzeb, E. Dawn Flick, Michael P. Kosty, Mansoor Raza Mirza, Julie R. Brahmer, Corey J. Langer and David R. Spigel. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.